
OmnigeniQ is a company leveraging cutting-edge biophysics and AI to address the high failure rate of drugs in human trials. Their core offering, JupitR, aims to understand and rectify the reasons behind these failures. The company's approach is rooted in principles of physics, quantum biology, and the health needs of astronauts in zero gravity, which has led to novel insights into protein and biological production.

OmnigeniQ is a company leveraging cutting-edge biophysics and AI to address the high failure rate of drugs in human trials. Their core offering, JupitR, aims to understand and rectify the reasons behind these failures. The company's approach is rooted in principles of physics, quantum biology, and the health needs of astronauts in zero gravity, which has led to novel insights into protein and biological production.